These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Hormone-induced spontaneous femoral neck fracture in a 28-year-old female patient]. Bala M; Bollheimer C; Schölmerich J; Schäffler A Med Klin (Munich); 2009 Mar; 104(3):244-8. PubMed ID: 19337715 [TBL] [Abstract][Full Text] [Related]
7. [Glucocorticoid-induced osteoporosis: recent findings]. Angeli A; Osella G; Reimondo G; Terzolo M Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891 [TBL] [Abstract][Full Text] [Related]
8. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643 [TBL] [Abstract][Full Text] [Related]
9. A juvenile case of Cushing's disease incidentally discovered with multiple bone fractures. Yoshihara A; Okubo Y; Tanabe A; Sata A; Nishimaki M; Kawamata T; Kubo O; Hori T; Takano K Intern Med; 2007; 46(9):583-7. PubMed ID: 17473494 [TBL] [Abstract][Full Text] [Related]
10. Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis. Chiodini I; Falchetti A; Merlotti D; Eller Vainicher C; Gennari L Expert Rev Endocrinol Metab; 2020 Jul; 15(4):283-298. PubMed ID: 32584619 [TBL] [Abstract][Full Text] [Related]
11. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up. Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286 [TBL] [Abstract][Full Text] [Related]
12. Novel approaches to bone comorbidity in Cushing's disease: an update. Frara S; di Filippo L; Doga M; Loli P; Casanueva FF; Giustina A Pituitary; 2022 Oct; 25(5):754-759. PubMed ID: 35849272 [TBL] [Abstract][Full Text] [Related]
13. [Osteoporosis in men]. Biver E; Uebelhart B Rev Med Suisse; 2013 Jun; 9(390):1260-4. PubMed ID: 23821844 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. Di Somma C; Colao A; Pivonello R; Klain M; Faggiano A; Tripodi FS; Merola B; Salvatore M; Lombardi G Clin Endocrinol (Oxf); 1998 May; 48(5):655-62. PubMed ID: 9666879 [TBL] [Abstract][Full Text] [Related]
15. [Prevalence, etiology and clinical findings of Cushing's syndrome]. Lahera Vargas M; da Costa CV Endocrinol Nutr; 2009 Jan; 56(1):32-9. PubMed ID: 19627706 [TBL] [Abstract][Full Text] [Related]
16. Cushing's disease as a cause of severe osteoporosis: a clinical challenge. Abdel-Kader N; Cardiel MH; Navarro Compan V; Piedra Priego J; González A Reumatol Clin; 2012; 8(5):278-9. PubMed ID: 22421455 [TBL] [Abstract][Full Text] [Related]
17. Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches. Langdahl B Bone; 2020 Oct; 139():115516. PubMed ID: 32622871 [TBL] [Abstract][Full Text] [Related]
18. Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Tauchmanovà L; Rossi R; Nuzzo V; del Puente A; Esposito-del Puente A; Pizzi C; Fonderico F; Lupoli G; Lombardi G Eur J Endocrinol; 2001 Sep; 145(3):241-7. PubMed ID: 11517003 [TBL] [Abstract][Full Text] [Related]
19. [Role of cortisol hypersecretion in the pathogenesis of osteoporosis]. Chiodini I; Scillitani A Recenti Prog Med; 2008 Jun; 99(6):309-13. PubMed ID: 18710063 [TBL] [Abstract][Full Text] [Related]
20. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]